N@N

New targeted therapies offered to patients

The article from MSN discusses the advent of new targeted therapies for cancer patients, focusing on treatments that are more precise in attacking cancer cells while minimizing damage to healthy cells. These therapies include drugs like monoclonal antibodies, tyrosine kinase inhibitors, and immune checkpoint inhibitors, which work by targeting specific molecules or pathways involved in cancer growth. The article highlights how these treatments are tailored to the genetic makeup of a patient's tumor, offering a more personalized approach to cancer care. It also mentions the potential benefits such as reduced side effects compared to traditional chemotherapy, improved survival rates, and better quality of life for patients. However, it notes the challenges including high costs, the need for specific diagnostic tests, and the fact that not all patients respond to these therapies. The piece concludes by emphasizing the ongoing research and development in this field, aiming to expand the range of cancers treatable with targeted therapies and to make these treatments more accessible.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/health/diseases-and-conditions/new-targeted-therapies-offered-to-patients/ar-AA1vu5t7 ]